This year, heart disease will affect more women in Canada than any other disease. Cardiovascular afflictions can include atherosclerosis, hypertension, stroke and heart attack.
Coenzyme Q10 (CoQ10) is an extremely important nutrient that every cell in your body must have in order to produce energy. It is naturally found in the energy-producing center of the cell known as the mitochondria, the part of a cell responsible for the production of energy in the form of ATP (Adenosine triphosphate). ATP serves as the cell's major energy source and drives a number of biological processes, including muscle contraction and the production of protein. CoQ10 is involved in making this important molecule.
Ubiquinone vs. Ubiquinol
Ubiquinone is the standard form of CoQ10. The body must automatically convert ubiquinone to ubiquinol - the most body-ready form of CoQ10 - to help in cell energy production by providing quick and efficient replenishment. Aging inhibits this conversion process hence the requirement for CoQ10 supplementation, where the body-ready ubiquinol form may achieve the most optimal benefits. Human clinical studies have shown that when compared to standard CoQ10 supplements ubiquinol is: 8x better absorbed in the bloodstream; reduces exercise-induced fatigue by 90%; and slows aging by 40%.
INNO-Q-NOL: Kaneka QH® Ubiquinol with Q-Nol® stability
Stabilized ubiquinol from ingredient to product expiration
Ubiquinol by nature is not stable (i.e. reverts back to ubiquinone). Kaneka Corporation, the world's primary CoQ10 producer, has developed a patented process that creates the most highly stabilized form of ubiquinol as a raw ingredient - Kaneka QH® Ubiquinol. While many supplement brands utilize Kaneka QH® Ubiquinol, how it’s handled during final manufacturing has a significant impact on the stabilized form and the degree and rate to which natural destabilization will occur. To ensure the superior efficacy of ubiquinol at the time of ingestion, Innovite Health utilizes one additional manufacturing step, the patented Q-Nol® process (US Patent 6,740,338) which ensures ubiquinol in the finished product stays stable (i.e. as ubiquinol) through to product expiration.